Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 5:43 PM ET


Company Overview of Neovacs S.A.

Executive Profile

Miguel Sieler

Chief Executive Officer and Director, Neovacs S.A.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Miguel Sieler serves as the Chief Executive Officer Circle, Life Sciences at Truffle Capital. Mr. Sieler focuses on life sciences. Earlier, he served as the Venture Partner at the firm. Mr. Sieler has been Chief Executive Officer at Neovacs S.A. since October 17, 2013 and its General Director since October 2013. He is Managing Director of Neovacs. He served as Chairman and Chief Executive Officer of Bayer France. Mr. Sieler served in various senior positions at Bayer ...

Corporate Headquarters

3-5, Impasse Reille
Paris, Ile-de-France 75014


Phone: 33 1 53 10 93 00
Fax: 33 1 53 10 93 03

Board Members Memberships

Director, Member of Audit & Accounts Committee and Member of Compensation & Appointments Committee
Chief Executive Officer and Director


Eberhard Karls Universität Tübingen
Institut d'Etudes Politiques de Paris

Other Affiliations

Annual Compensation

Total Annual Compensation€182,054

Stocks Options

All Other Compensation€1,160

Total Compensation

Total Annual Cash Compensation€183,214
Total Short Term Compensation€182,053
Other Long Term Compensation€1,160
Total Calculated Compensation€183,214

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neovacs S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at